메뉴 건너뛰기




Volumn 25, Issue 4, 2008, Pages 344-346

Argatroban therapy in patients with hepatic and renal impairment

Author keywords

[No Author keywords available]

Indexed keywords

ARGATROBAN; DANAPAROID; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

EID: 40549132574     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021507002839     Document Type: Letter
Times cited : (9)

References (7)
  • 1
    • 12444310249 scopus 로고    scopus 로고
    • Alternative parenteral anticoagulation with argatroban, a direct thrombin inhibitor
    • LaMonte MP, Brown PM, Hursting MJ. Alternative parenteral anticoagulation with argatroban, a direct thrombin inhibitor. Expert Rev Cardiovasc Ther 2005; 3: 31-41.
    • (2005) Expert Rev Cardiovasc Ther , vol.3 , pp. 31-41
    • LaMonte, M.P.1    Brown, P.M.2    Hursting, M.J.3
  • 2
    • 0034049121 scopus 로고    scopus 로고
    • The pharmacokinetics and pharmacodynamics of argatroban: Effects of age, gender, and hepatic or renal dysfunction
    • Swan SK, Hursting MJ. The pharmacokinetics and pharmacodynamics of argatroban: effects of age, gender, and hepatic or renal dysfunction. Pharmacotherapy 2000; 20: 318-329.
    • (2000) Pharmacotherapy , vol.20 , pp. 318-329
    • Swan, S.K.1    Hursting, M.J.2
  • 3
    • 18844400887 scopus 로고    scopus 로고
    • Extensive prolongation of aPTT with argatroban in an elderly patient with improving renal function, normal hepatic enzymes, and metastatic lung cancer
    • Kubiak DW, Szumita PM, Fanikos JR. Extensive prolongation of aPTT with argatroban in an elderly patient with improving renal function, normal hepatic enzymes, and metastatic lung cancer. Ann Pharmacother 2005; 39: 1119-1123.
    • (2005) Ann Pharmacother , vol.39 , pp. 1119-1123
    • Kubiak, D.W.1    Szumita, P.M.2    Fanikos, J.R.3
  • 4
    • 12444302398 scopus 로고    scopus 로고
    • A prospective comparison of three argatroban treatment regimens during hemodialysis in endstage renal disease
    • Murray PT, Reddy BV, Grossman EJ et al. A prospective comparison of three argatroban treatment regimens during hemodialysis in endstage renal disease. Kidney Int 2004; 66: 2446-2453.
    • (2004) Kidney Int , vol.66 , pp. 2446-2453
    • Murray, P.T.1    Reddy, B.V.2    Grossman, E.J.3
  • 5
    • 0041422394 scopus 로고    scopus 로고
    • Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD
    • Dager WE, White RH. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD. Ann Pharmacother 2003; 37: 1232-1236.
    • (2003) Ann Pharmacother , vol.37 , pp. 1232-1236
    • Dager, W.E.1    White, R.H.2
  • 7
    • 33144478643 scopus 로고    scopus 로고
    • Successful recovery after an overdose of argatroban
    • Yee AJ, Kuter DJ. Successful recovery after an overdose of argatroban. Ann Pharmacother 2006; 40: 336-339.
    • (2006) Ann Pharmacother , vol.40 , pp. 336-339
    • Yee, A.J.1    Kuter, D.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.